Clinical Trial Update: APSV in Vaccinia Naive Adults [Phase 2]

View source ↗

Summary

Phase 2 trial of APSV in vaccinia-naive adults for smallpox has completed, according to a ClinicalTrials.gov update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• APSV

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Smallpox | Phase 2 | Status: COMPLETED